News

.

Department of Biomedicine Newsletter No. 11

We are pleased to announce the release of the eleventh edition of our DBM newsletter. We hope you enjoy reading it!

.
/ News, Research

Combining Forces: Fusion Protein Boosts Immune Attack on Cancer (Zippelius Lab)

Harnessing the body’s immune system has transformed cancer treatment, yet current immunotherapies are often limited by toxicity or by the ability of tumors to silence immune cells. A new study from Irene Fusi and Clara Serger et al. in…

.
/ News, Research

A Step Forward in Precision Medicine: Novel BiTE Immunotherapy for High-Risk CLL (Binder Lab)

Chronic lymphocytic leukemia (CLL) is a malignant B-cell disease whose course is strongly influenced by the configuration of the B-cell receptor (BCR). A well-known high-risk marker is the IGLV3-21-R110 mutation, found in about 10–15% of…

.
/ News, People

ERC Starting Grants Awarded to Four DBM Researchers

"What if we could re-energize exhausted immune cells to fight cancer again? Or slow down the aging process of our immune system? What if we could stop breast cancer from spreading? What if there were better cellular immunotherapies to fight…

.
/ News, People

Welcome to the Team – Marc Busche Lab!

Professor Dr. Marc Aurel Busche has been appointed Clinical Professor of Dementia at the Medical Faculty of the University of Basel, Head of the Memory Clinic and Geriatric Psychiatry Department at the Felix Platter University Hospital, and…

To top